As on Thursday, Annovis Bio Inc (NYSE: ANVS) started slowly as it slid -5.76% to $2.29, before settling in for the price of $2.43 at the close. Taking a more long-term approach, ANVS posted a 52-week range of $1.11-$7.77.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -73.95%. Meanwhile, its Annual Earning per share during the time was -73.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 45.54%. This publicly-traded company’s shares outstanding now amounts to $26.11 million, simultaneously with a float of $23.22 million. The organization now has a market capitalization sitting at $59.80 million. At the time of writing, stock’s 50-day Moving Average stood at $2.14, while the 200-day Moving Average is $2.21.
Annovis Bio Inc (ANVS) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Annovis Bio Inc’s current insider ownership accounts for 14.86%, in contrast to 10.86% institutional ownership. According to the most recent insider trade that took place on Oct 28 ’25, this organization’s President & CEO bought 97,561 shares at the rate of 2.05, making the entire transaction reach 200,000 in total value, affecting insider ownership by 1,212,020. Preceding that transaction, on Oct 28 ’25, Company’s Director bought 975,610 for 2.05, making the whole transaction’s value amount to 2,000,000. This particular insider is now the holder of 2,455,539 in total.
Annovis Bio Inc (ANVS) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.37 per share during the current fiscal year. Annovis Bio Inc’s EPS increase for this current 12-month fiscal period is 45.54% and is forecasted to reach -1.22 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 21.65% through the next 5 years, which can be compared against the -73.95% growth it accomplished over the previous five years trading on the market.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
Let’s observe the current performance indicators for Annovis Bio Inc (ANVS). It’s Quick Ratio in the last reported quarter now stands at 4.60.
In the same vein, ANVS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.48, a figure that is expected to reach -0.31 in the next quarter, and analysts are predicting that it will be -1.22 at the market close of one year from today.
Technical Analysis of Annovis Bio Inc (ANVS)
Through scrutinizing the latest numbers posted by the [Annovis Bio Inc, ANVS], it can be observed that its last 5-days Average volume of 0.56 million was better the volume of 0.51 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 72.68% While, its Average True Range was 60.49.
Raw Stochastic average of Annovis Bio Inc (ANVS) in the period of the previous 100 days is set at 50.35%, which indicates a major fall in contrast to 66.78% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.17 that was higher than 0.17 volatility it exhibited in the past 100-days period.
